Engineered transcription factors for therapeutic angiogenesis

Christopher D. Kontos, Brian H. Annex

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Angiogenesis is defined as the growth and proliferation of blood vessels from existing vascular structures. Therapeutic angiogenesis seeks to harness the mechanisms of vascular growth to treat disorders of inadequate tissue perfusion. Early clinical trials of therapeutic angiogenesis met with limited success, in part due to the complex spatial and temporal regulation of angiogenesis, which requires the coordinate action of multiple growth factors and their receptors. Engineered transcription factors represent a novel and innovative approach to modulate this process as they offer the ability to induce expression of multiple angiogenic genes simultaneously. The rational design of these transcription factor agents, results of their use in preclinical models of ischemic disease and prospects for their use in human investigations are discussed in this review.

Original languageEnglish (US)
Pages (from-to)145-152
Number of pages8
JournalCurrent Opinion in Molecular Therapeutics
Volume9
Issue number2
StatePublished - Apr 1 2007
Externally publishedYes

Keywords

  • Angiogenesis
  • Endothelium
  • Growth factors
  • Ischemia
  • Therapeutic angiogenesis
  • Vascular disease

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Engineered transcription factors for therapeutic angiogenesis'. Together they form a unique fingerprint.

  • Cite this